Experts highlight access challenges in South Africa's Lenacapavir HIV prevention rollout
IOL
—
Researchers say South Africa's rollout of the long-acting HIV prevention injection Lenacapavir has the potential to transform HIV prevention, but warn that equitable access and stronger community-based healthcare will determine its success.